These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7829797)

  • 21. Left ventricular diastolic dysfunction in essential hypertension.
    Avdić S; Mujcinović Z; Asćerić M; Nukić S; Kusljugić Z; Smajić E; Arapcić S
    Bosn J Basic Med Sci; 2007 Feb; 7(1):15-20. PubMed ID: 17489762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Losartan and amlodipine on myocardial structure and function: a prospective, randomized, clinical trial.
    Fogari R; Mugellini A; Destro M; Corradi L; Lazzari P; Zoppi A; Preti P; Derosa G
    Diabet Med; 2012 Jan; 29(1):24-31. PubMed ID: 21781149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new approach for evaluation of left ventricular diastolic function: spatial and temporal analysis of left ventricular filling flow propagation by color M-mode Doppler echocardiography.
    Takatsuji H; Mikami T; Urasawa K; Teranishi J; Onozuka H; Takagi C; Makita Y; Matsuo H; Kusuoka H; Kitabatake A
    J Am Coll Cardiol; 1996 Feb; 27(2):365-71. PubMed ID: 8557907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left Ventricular Hypertrophy Regression During Antihypertensive Treatment in an Outpatient Clinic (the Campania Salute Network).
    Lønnebakken MT; Izzo R; Mancusi C; Gerdts E; Losi MA; Canciello G; Giugliano G; De Luca N; Trimarco B; de Simone G
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28275070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left ventricular hypertrophy and its regression in essential arterial hypertension. A tissue Doppler imaging study.
    Di Bello V; Giorgi D; Pedrinelli R; Talini E; Palagi C; Delle Donne MG; Zucchelli G; Dell'omo G; Di Cori A; Dell'Anna R; Caravelli P; Mariani M
    Am J Hypertens; 2004 Oct; 17(10):882-90. PubMed ID: 15485749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in left ventricular structure and function following renal artery revascularization.
    Corriere MA; Hoyle JR; Craven TE; D'Agostino RB; Edwards MS; Moore PS; Hansen KJ
    Ann Vasc Surg; 2010 Jan; 24(1):80-4. PubMed ID: 19631505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Test-retest reliability of new and conventional echocardiographic parameters of left ventricular systolic function.
    Baron T; Berglund L; Hedin EM; Flachskampf FA
    Clin Res Cardiol; 2019 Apr; 108(4):355-365. PubMed ID: 30368567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antihypertensive treatment in hypertensive patients with normal left ventricular mass is associated with left ventricular remodeling and improved diastolic function.
    Schulman DS; Flores AR; Tugoen J; Dianzumba S; Reichek N
    Am J Cardiol; 1996 Jul; 78(1):56-60. PubMed ID: 8712119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood pressure variability in controlled and uncontrolled blood pressure and its association with left ventricular hypertrophy and diastolic function.
    Wittke EI; Fuchs SC; Moreira LB; Foppa M; Fuchs FD; Gus M
    J Hum Hypertens; 2016 Aug; 30(8):483-7. PubMed ID: 26467817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of left atrial reservoir function with left atrial structural remodeling related to left ventricular dysfunction in asymptomatic patients with hypertension: evaluation by two-dimensional speckle-tracking echocardiography.
    Miyoshi H; Oishi Y; Mizuguchi Y; Iuchi A; Nagase N; Ara N; Oki T
    Clin Exp Hypertens; 2015; 37(2):155-65. PubMed ID: 25050647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inappropriate left ventricular mass: Reliability and limitations of echocardiographic measurement for risk stratification and follow-up in single patients.
    Muiesan ML; de Simone G; Ganau A; Longhini C; Verdecchia P; Mancia G; Agabiti-Rosei E;
    J Hypertens; 2006 Nov; 24(11):2293-8. PubMed ID: 17053553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between left ventricular mass and blood pressure in treated hypertension.
    Missault LH; De Buyzere ML; De Bacquer DD; Duprez DD; Clement DL
    J Hum Hypertens; 2002 Jan; 16(1):61-6. PubMed ID: 11840231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: the LIFE study.
    Palmieri V; Wachtell K; Gerdts E; Bella JN; Papademetriou V; Tuxen C; Nieminen MS; Dahlöf B; de Simone G; Devereux RB
    Am Heart J; 2001 May; 141(5):784-91. PubMed ID: 11320367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
    Wachtell K; Dahlöf B; Rokkedal J; Papademetriou V; Nieminen MS; Smith G; Gerdts E; Boman K; Bella JN; Devereux RB
    Am Heart J; 2002 Dec; 144(6):1057-64. PubMed ID: 12486431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
    Gottdiener JS; Reda DJ; Massie BM; Materson BJ; Williams DW; Anderson RJ
    Circulation; 1997 Apr; 95(8):2007-14. PubMed ID: 9133508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mechanism of reduced longitudinal left ventricular systolic function in hypertensive patients with normal ejection fraction.
    Szelényi Z; Fazakas Á; Szénási G; Tegze N; Fekete B; Molvarec A; Hadusfalvy-Sudár S; Jánosi O; Kiss M; Karádi I; Vereckei A
    J Hypertens; 2015 Sep; 33(9):1962-9; discussion 1969. PubMed ID: 26154942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Losartan reduces left ventricular hypertrophy proportionally to blood pressure reduction in hypertensives, but does not affect diastolic cardiac function.
    Zakynthinos E; Pierutsakos Ch; Konstantinidis K; Zakynthinos S; Papadogiannis D
    Angiology; 2004; 55(6):669-78. PubMed ID: 15547653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse Cardiac Events and the Impaired Relaxation Left Ventricular Filling Pattern.
    Lavine SJ; Al Balbissi K
    J Am Soc Echocardiogr; 2016 Jul; 29(7):699-708. PubMed ID: 27004828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvement of diastolic function after regression of left ventricular hypertrophy.
    Teniente-Valente R; Solorio S; Vargas-Salado E; Aguirre-Vázquez C; Hernández-González MA; Olvera-Lopez JA; Rodríguez-Mariscal L; Luna-Ruiz MA; Guillén Contreras JM; Murillo Ortiz BO
    Arch Cardiol Mex; 2008; 78(4):392-9. PubMed ID: 19205547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early predictors of alterations in left atrial structure and function related to left ventricular dysfunction in asymptomatic patients with hypertension.
    Miyoshi H; Oishi Y; Mizuguchi Y; Iuchi A; Nagase N; Ara N; Oki T
    J Am Soc Hypertens; 2013; 7(3):206-15. PubMed ID: 23538140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.